Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
T cell receptor alpha variable 38-1 (TRAV38-1) is a protein-coding gene that encodes the variable region of the alpha chain of the T cell receptor (TCR) complex[1][3]. The T cell receptor is a disulfide-linked, membrane-anchored heterodimer on the surface of T lymphocytes, responsible for recognizing foreign antigens presented as peptide fragments bound to major histocompatibility complex (MHC) molecules on antigen-presenting cells[2]. Each TCR is composed of an alpha and beta chain (or less commonly, gamma and delta chains), with diversity generated via somatic recombination (V-J for alpha chains, with TRAV38-1 being one of the variable gene segments)[1][2][3]. The binding of TCR to peptide-MHC (pMH) complexes initiates a cascade of intracellular signaling, leading to T cell activation, differentiation, and immune response[1][3]. While TCR alpha variable 38-1 itself is a gene segment contributing to the diversity of the TCR repertoire, it is not considered a direct therapeutic target, nor is it associated with specific drug interactions or biomarker roles.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on T cell receptor alpha variable 38-1 (TRAV38-1).